[英文文献] Too Much of a Good Thing: The Role of Alliance Portfolio Diversity for Inno... [推广有奖]

0关注
0粉丝

等待验证会员

学前班

还不是VIP/贵宾

威望: 0 级
论坛币: 0 个
通用积分: 0
学术水平: 0 点
热心指数: 0 点
信用等级: 0 点
经验: 10 点
帖子: 0
精华: 0
在线时间: 0 小时
注册时间: 2020-9-19
最后登录: 2020-9-19

楼主

社保缴费率714 发表于 2005-1-7 10:45:13 |AI写论文

是否 +2 论坛币

k人参与回答

经管之家送您一份

应届毕业生专属福利!

求职就业群

赵安豆老师微信：zhaoandou666

经管之家联合CDA

送您一个全额奖学金名额~ !

立即领取

感谢您参与论坛问题回答

经管之家送您两个论坛币！

+2 论坛币

英文文献：Too Much of a Good Thing: The Role of Alliance Portfolio Diversity for Innovation Output in the Biotechnology Industry-好事过犹不及:在生物技术产业中，联盟组合多样性对创新产出的作用
英文文献作者：Wilfried Zidorn,Marcus Wagner
英文文献摘要：
The purpose of this paper is to show the impact of heterogeneous partners in a biotechnology firm’s alliance portfolio on innovation output. Previous literature has stressed that investments into the heterogeneity of partners in an alliance portfolio is more important than just engaging in multiple collaborative agreements. The analysis of a unique panel dataset of 20 biotechnology firms and their 8502 alliances suggests that engaging in many alliances in general has a positive influence on a firms innovation output. Furthermore, maintaining diverse alliance portfolios has an inverted U-shaped influence on a firm’s innovation output, as managerial costs and complexity levels become too high.

摘要本文旨在探讨生物科技企业联盟组合中异质合作伙伴对创新产出的影响。以往的文献强调，在联盟投资组合中，投资于合作伙伴的异质性比仅仅参与多个合作协议更重要。对20家生物技术公司及其8502联盟的独特面板数据集的分析表明，参与许多联盟通常对公司的创新产出有积极的影响。此外，当管理成本和复杂性水平变得过高时，维持多样化的联盟组合对公司的创新产出有倒u型的影响。